Industry leaders respond to PM Modi’s Ayushman Bharat speech on Independence Day
PM launches Ayushman Bharat to cover 50 crore people; industry leaders welcome it as a landmark step toward affordable, universal healthcare.
Read More
MTaI points out concerns in the ‘National Health Protection Scheme’
Ahead of NHPS launch, MTaI urges inclusion of MedTech in planning, fair package rates, quality oversight, and skill building for success.
Read More
Global medical device makers unhappy over stent price cap
MTaI warns stent price caps may distort markets, deter global investment, and urges balanced regulation, GST relief, and patient-safety safeguards.
Read More
MTaI Seeks Level Playing Field for International Medical Device Industry in India
MTaI urges balanced regulation to ensure quality healthcare, warning harsh price caps, GST, and misuse of devices could hurt patients and innovation.
Read More
MTaI seeks level playing field for global medical device industry in India
MTaI urges balanced regulation to ensure quality healthcare, warning harsh price caps, GST, and misuse of devices could harm patients and innovation.
Read More
10% price hike cap on most medical devices
NPPA allows up to 10% annual price hikes for most medical devices, caps stents, and warns of strict action against overcharging.
Read More
Cut in stent prices to hit biz environment, says association
Sharp stent price cuts could hurt markets and R&D, prompting calls for broader regulation, GST relief for healthcare, and checks on reuse of single-use devices.
Read More
Budget 2017: Gold for medical device sector, and a cold breeze to healthcare industry
Budget boosts medical devices and education, but falls short of pharma growth goals; industry welcomes device rules and global harmonisation push.
Read More
A Cautious Approach To GST Would Catapult India To High-Ranking Economies Of The World
Medtech leaders urge GST to keep healthcare and devices low-taxed, warning higher duties and rates could raise costs and hurt access.
Read More